APOTEX FDA Friday, April 6, 2012 0.00 Neutral

FDA Approves Unknown Drug — APOTEX INC

Apotex Inc. received FDA approval for Abbreviated New Drug Application (ANDA) #091308, signaling its entry into the market with a generic alternative that is anticipated to increase competition and pressure pricing within the relevant therapeutic class.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day